These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 15869924

  • 1. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene.
    Balemans W, Cleiren E, Siebers U, Horst J, Van Hul W.
    Bone; 2005 Jun; 36(6):943-7. PubMed ID: 15869924
    [Abstract] [Full Text] [Related]

  • 2. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?
    Balemans W, Van Hul W.
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113
    [Abstract] [Full Text] [Related]

  • 3. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.
    Piters E, Culha C, Moester M, Van Bezooijen R, Adriaensen D, Mueller T, Weidauer S, Jennes K, de Freitas F, Löwik C, Timmermans JP, Van Hul W, Papapoulos S.
    Hum Mutat; 2010 Jul; 31(7):E1526-43. PubMed ID: 20583295
    [Abstract] [Full Text] [Related]

  • 4. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
    van Bezooijen RL, ten Dijke P, Papapoulos SE, Löwik CW.
    Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
    [Abstract] [Full Text] [Related]

  • 5. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.
    Sebastian A, Loots GG.
    Metabolism; 2018 Mar; 80():38-47. PubMed ID: 29080811
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.
    Staehling-Hampton K, Proll S, Paeper BW, Zhao L, Charmley P, Brown A, Gardner JC, Galas D, Schatzman RC, Beighton P, Papapoulos S, Hamersma H, Brunkow ME.
    Am J Med Genet; 2002 Jun 15; 110(2):144-52. PubMed ID: 12116252
    [Abstract] [Full Text] [Related]

  • 10. Bone morphogenetic proteins and their antagonists: the sclerostin paradigm.
    van Bezooijen RL, Papapoulos SE, Löwik CW.
    J Endocrinol Invest; 2005 Jun 15; 28(8 Suppl):15-7. PubMed ID: 16323824
    [Abstract] [Full Text] [Related]

  • 11. Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family.
    He WT, Chen C, Pan C, Zhang MX, Yu XF, Wang DW, Hu SH.
    Clin Genet; 2016 Feb 15; 89(2):205-9. PubMed ID: 26283468
    [Abstract] [Full Text] [Related]

  • 12. Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.
    Whyte MP, Deepak Amalnath S, McAlister WH, Pedapati R, Muthupillai V, Duan S, Huskey M, Bijanki VN, Mumm S.
    Bone; 2018 Nov 15; 116():321-332. PubMed ID: 30077757
    [Abstract] [Full Text] [Related]

  • 13. Novel SOST gene mutation in a sclerosteosis patient and her parents.
    Bhadada SK, Rastogi A, Steenackers E, Boudin E, Arya A, Dhiman V, Bhansali A, Van Hul W.
    Bone; 2013 Feb 15; 52(2):707-10. PubMed ID: 23079137
    [Abstract] [Full Text] [Related]

  • 14. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.
    Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van Hul W.
    J Med Genet; 2002 Feb 15; 39(2):91-7. PubMed ID: 11836356
    [Abstract] [Full Text] [Related]

  • 15. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).
    Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W.
    Hum Mol Genet; 2001 Mar 01; 10(5):537-43. PubMed ID: 11181578
    [Abstract] [Full Text] [Related]

  • 16. Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.
    Loots GG, Kneissel M, Keller H, Baptist M, Chang J, Collette NM, Ovcharenko D, Plajzer-Frick I, Rubin EM.
    Genome Res; 2005 Jul 01; 15(7):928-35. PubMed ID: 15965026
    [Abstract] [Full Text] [Related]

  • 17. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
    van Lierop AH, Hamdy NA, Hamersma H, van Bezooijen RL, Power J, Loveridge N, Papapoulos SE.
    J Bone Miner Res; 2011 Dec 01; 26(12):2804-11. PubMed ID: 21786318
    [Abstract] [Full Text] [Related]

  • 18. A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis.
    Fayez A, Aglan M, Esmaiel N, El Zanaty T, Abdel Kader M, El Ruby M.
    Biomed Res Int; 2015 Dec 01; 2015():517815. PubMed ID: 25984533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.
    Ekhzaimy AA, Alyusuf EY, Alswailem M, Alzahrani AS.
    Medicina (Kaunas); 2022 Jan 28; 58(2):. PubMed ID: 35208525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.